View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
September 12, 2010

AtheroMed Initiates Atherectomy Catheter Trial

AtheroMed has started to enrol patients for a clinical trial of its Phoenix atherectomy catheter, a device to treat peripheral arterial disease in the legs. The FDA-approved investigational device exemption clinical trial will evaluate the safety and effectiveness of the catheter, and wi

By cms admin

AtheroMed has started to enrol patients for a clinical trial of its Phoenix atherectomy catheter, a device to treat peripheral arterial disease in the legs.

The FDA-approved investigational device exemption clinical trial will evaluate the safety and effectiveness of the catheter, and will involve 90 patients across 20 clinical sites.

The Phoenix Atherectomy catheter will enable surgeons to cut, capture and pass the arterial plaque into an external bag.

The device is front-cutting and has a deflectable tip which enables the treatment of range of blood vessels sizes.

AtheroMed president and CEO Will McGuire said the catheter had been developed to provide physicians with a safe, versatile, easy to use alternative for treating peripheral arterial disease in the legs.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management